INmune Bio
INMB
INmune Bio (INMB) news
Recent news
Inmune Bio Q2 basic EPS USD -0.05
AInvest Wire · Aug 6, 2026Inmune Bio Q2 operating expenses USD 1.476 million
AInvest Wire · Aug 6, 2026Inmune Bio Inc - receives R&D rebates of approximately $4.6 mln
INmune Bio Inc. (NASDAQ: INMB) reported receiving R&D rebates of approximately $4.6 million in 2026, including a $3.6 million rebate from Australia and an additional $1 million from the United Kingdom. These rebates were reinvested into clinical programs , particularly its Alzheimer’s Disease (AD)…
AInvest Wire · Jul 31, 2026Inmune Bio receives R&D rebates of approximately $4.6 million
AInvest Wire · Jul 31, 2026Inmune Bio - CordStrom to file MAA with UK MHRA and EU EMA in 2026; U.S. BLA planned
AInvest Wire · Jul 15, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.